Skip to main content
NIH funding notice PAR-16-300

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)

Closed on October 26, 2017.

Posted
May 31, 2016
Close date
October 26, 2017
Activity codes
UG3, UH3
Institutes taking part
NHLBI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-18-407.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,375,880 in first-year total cost, median $633,736.

Most frequent study sections

  1. Clinical Trials Review Study Section[CLTR (MA)]4
  2. Clinical Trials Review Study Section[CLTR (OA)]2
  3. Special Emphasis Panel[ZHL1 CSR-H (F2)]1

Most frequent institutions

  1. CHILDREN'S HOSP OF PHILADELPHIA1
  2. DUKE UNIVERSITY1
  3. OHIO STATE UNIVERSITY1
  4. UNIVERSITY OF IOWA1
  5. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PAR-16-300 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
20181/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC)1UG3HL141736-01CHEIFETZ, IRA MCURLEY, MARTHA AQKNEYBER, MARTINUNIVERSITY OF PENNSYLVANIA, PA$1,718,755ZHL1
2018Impact of Low Flow Nocturnal Oxygen Therapy On Hospital Readmission/Mortalityin Patients with Heart Failure and Central Sleep Apneal (LOFT-HF)1UG3HL140144-01ABRAHAM, WILLIAM TOBEROHIO STATE UNIVERSITY, OH$742,108CLTR
2018Transfusion of Prematurity Early School Age Follow-up (TOP 5) CCC1UG3HL143204-01DEMAURO, SARA BONAMONOPOULOS, PEGGY CUNIVERSITY OF IOWA, IA$633,736CLTR
20181/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)1UG3HL137856-01A1TANABE, PAULADUKE UNIVERSITY, NC$431,577CLTR
20181/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women1UG3HL140131-01COSTANTINE, MAGEDLAWRENCE CLEARY, KIRSTENSAADE, GEORGE R.WAPNER, RONALDUNIVERSITY OF TEXAS MED BR GALVESTON, TX$153,314CLTR
20171/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)1UG3HL138325-01VEDANTHAM, SURESHWASHINGTON UNIVERSITY, MO$1,376,983CLTR
20171/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center1UG3HL137872-01DEMAURO, SARA BONAMOHINTZ, SUSANKALLAPUR, SUHASKIRPALANI, HARESHCHILDREN'S HOSP OF PHILADELPHIA, PA$319,407CLTR

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-300: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) | ScienceDex | ConductScience